Regeneron Pharma
REGN----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Regeneron Pharma(REGN) predict that the Revenue is 3.605 B (+19.04%), Beat estimate;the EBIT is 1.045 B (+19.12%), Beat estimate;the EPS is 6.75 (-7.15%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
3.61B19.04%
3.48B15.01%
+0.12B4.03%
EBITExceed expectations
1.04B19.12%
0.95B8.50%
+0.09B10.62%
EPSMiss expectations
6.757.15%
8.603318.34%
-1.853325.49%
Upcoming earnings report - FY2026 Q2 Earning Release
Available dateJul 30, 2026
Estimate Revenue3.825 B
Estimate EBIT1.189 B
Estimate EPS8.7883
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf